Operating Margin in % of Regen BioPharma Inc from 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Regen BioPharma Inc quarterly/annual Operating Margin history and change rate from 2015 to Q2 2024.
  • Regen BioPharma Inc Operating Margin for the quarter ending 30 Jun 2024 was -309 %, a 34.5% increase year-over-year.
  • Regen BioPharma Inc annual Operating Margin for 2023 was -543 %, a 101% decline from 2022.
  • Regen BioPharma Inc annual Operating Margin for 2022 was -271 %, a 17.5% increase from 2021.
  • Regen BioPharma Inc annual Operating Margin for 2021 was -328 %, a 72.4% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Regen BioPharma Inc Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -309 +162 +34.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -291 +263 +47.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -273 +282 +50.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -543 -272 -101% 01 Jul 2023 30 Sep 2023
Q2 2023 -471 +47.9 +9.22% 01 Apr 2023 30 Jun 2023
Q1 2023 -554 -43.1 -8.44% 01 Jan 2023 31 Mar 2023
Q4 2022 -555 -114 -25.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -271 +57.5 +17.5% 01 Jul 2022 30 Sep 2022
Q2 2022 -519 -436 -525% 01 Apr 2022 30 Jun 2022
Q1 2022 -511 -450 -743% 01 Jan 2022 31 Mar 2022
Q4 2021 -441 -357 -422% 01 Oct 2021 31 Dec 2021
Q3 2021 -328 -138 -72.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -83.1 +262 +75.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -60.6 +395 +86.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -84.6 +545 +86.6% 01 Oct 2020 31 Dec 2020
Q3 2020 -190 +498 +72.3% 01 Jul 2020 30 Sep 2020
Q2 2020 -345 +312 +47.5% 01 Apr 2020 30 Jun 2020
Q1 2020 -456 -115 -33.6% 01 Jan 2020 31 Mar 2020
Q4 2019 -630 -45 -7.7% 01 Oct 2019 31 Dec 2019
Q3 2019 -688 +738 +51.7% 01 Jul 2019 30 Sep 2019
Q2 2019 -657 +1.56K +70.4% 01 Apr 2019 30 Jun 2019
Q1 2019 -341 +2.06K +85.8% 01 Jan 2019 31 Mar 2019
Q4 2018 -585 +2.01K +77.5% 01 Oct 2018 31 Dec 2018
Q3 2018 -1.43K +857 +37.5% 01 Jul 2018 30 Sep 2018
Q2 2018 -2.22K 01 Apr 2018 30 Jun 2018
Q1 2018 -2.4K 01 Jan 2018 31 Mar 2018
Q4 2017 -2.6K 01 Oct 2017 31 Dec 2017
Q3 2017 -2.28K 01 Jul 2017 30 Sep 2017

Regen BioPharma Inc Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -543 -272 -101% 01 Oct 2022 30 Sep 2023
2022 -271 +57.5 +17.5% 01 Oct 2021 30 Sep 2022
2021 -328 -138 -72.4% 01 Oct 2020 30 Sep 2021
2020 -190 +498 +72.3% 01 Oct 2019 30 Sep 2020
2019 -688 +738 +51.7% 01 Oct 2018 30 Sep 2019
2018 -1.43K +857 +37.5% 01 Oct 2017 30 Sep 2018
2017 -2.28K +674 +22.8% 01 Oct 2016 30 Sep 2017
2016 -2.96K -1.93K -187% 01 Oct 2015 30 Sep 2016
2015 -1.03K 01 Oct 2014 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.